Chemiluminescence and Bioluminescence as an Excitation Source in the Photodynamic Therapy of Cancer: A Critical Review

Chemphyschem. 2016 Aug 4;17(15):2286-94. doi: 10.1002/cphc.201600270. Epub 2016 May 25.

Abstract

Photodynamic therapy (PDT) of cancer is known for its limited number of side effects, and requires light, oxygen and photosensitizer. However, PDT is limited by poor penetration of light into deeply localized tissues, and the use of external light sources is required. Thus, researchers have been studying ways to improve the effectiveness of this phototherapy and expand it for the treatment of the deepest cancers, by using chemiluminescent or bioluminescent formulations to excite the photosensitizer by intracellular generation of light. The aim of this Minireview is to give a précis of the most important general chemi-/bioluminescence mechanisms and to analyze several studies that apply them for PDT. These studies have demonstrated the potential of utilizing chemi-/bioluminescence as excitation source in the PDT of cancer, besides combining new approaches to overcome the limitations of this mode of treatment.

Keywords: bioluminescence; cancer; chemiluminescence; photodynamic therapy; reactive oxygen species.

Publication types

  • Review

MeSH terms

  • Animals
  • Firefly Luciferin / metabolism
  • Humans
  • Imidazoles / metabolism
  • Luciferases, Firefly / metabolism
  • Luciferases, Renilla / metabolism
  • Luminescence
  • Luminescent Agents / metabolism
  • Luminol / metabolism
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Photochemotherapy / methods*
  • Photosensitizing Agents / metabolism
  • Photosensitizing Agents / therapeutic use*
  • Pyrazines / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Imidazoles
  • Luminescent Agents
  • Photosensitizing Agents
  • Pyrazines
  • Reactive Oxygen Species
  • coelenterazine
  • Luminol
  • Firefly Luciferin
  • Luciferases, Renilla
  • Luciferases, Firefly